Published on
January 28, 2022
- 07:33 GMT
Oncogen Pharma (Malaysia) Sdn. Bhd. Received the First ANDA Approval for Abiraterone 250mg and 500mg Tablets
The product will be marketed by the group’s front end, Novugen Pharma (USA) LLC, which is based in Princeton, New Jersey. SHAH ALAM, SELANGOR, MALAYSIA, January 28, 2022 /EINPresswire.com/ -- Oncogen Pharma (Malaysia) Sdn. Bhd., the sister concern of …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
